Thu, December 5, 2024
[ Thu, Dec 05th 2024 ]: MSN
Threads is testing post analytics
Wed, December 4, 2024
Tue, December 3, 2024
Mon, December 2, 2024
Sun, December 1, 2024
Sat, November 30, 2024
Fri, November 29, 2024

Indian-origin CEO strikes 'significant' UK deal to combat cancer, dementia


  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. gnificant-uk-deal-to-combat-cancer-dementia.html
  Print publication without navigation Published in Science and Technology on by Tim Hastings
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source


  Gordon Sanghera, CEO of Oxford Nanopore Technologies, said the development of a world-first "epigenetic map" of the human genome could lead to breakthroughs in new diagnoses and treatments.

The article from India Today discusses how Harpal Kumar, an Indian-origin CEO of the UK-based charity Cancer Research UK, has facilitated a significant deal with the UK government aimed at combating cancer and dementia. This deal, part of a broader initiative to enhance health research, involves a £100 million investment to accelerate the development of new treatments and diagnostics for these diseases. The agreement seeks to leverage the UK's strengths in life sciences to foster innovation, improve patient outcomes, and potentially save lives by advancing research into early detection and personalized medicine. The initiative also aims to create jobs and stimulate economic growth in the health sector.

Read the Full India Today Article at:
[ https://www.indiatoday.in/world/uk-news/story/indian-origin-ceo-strikes-significant-uk-deal-to-combat-cancer-dementia-2643887-2024-12-02 ]

Publication Contributing Sources